How to manage myoclonus after subarachnoid (spinal) block?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Myoclonus After Subarachnoid Block

For myoclonus following subarachnoid (spinal) block, first-line treatment should include benzodiazepines such as clonazepam, followed by antiepileptic medications like levetiracetam or sodium valproate if benzodiazepines are ineffective. 1, 2

Clinical Assessment and Immediate Management

  • Assess severity and pattern:

    • Determine if myoclonus is focal, multifocal, or generalized
    • Evaluate if movements are continuous (status myoclonus) or intermittent
    • Monitor for respiratory compromise or desaturation
  • Initial interventions:

    1. Benzodiazepines: Start with IV clonazepam (first-line for subcortical/brainstem myoclonus) 1, 2
    2. Respiratory support: Provide supplemental oxygen and monitor oxygen saturation closely
    3. Hemodynamic monitoring: Check vital signs frequently, especially if sedatives are administered

Pharmacological Management Algorithm

  1. First-line therapy:

    • Clonazepam: 0.5-2 mg IV initially, may repeat as needed 2
    • If ineffective after 10-15 minutes, proceed to second-line therapy
  2. Second-line therapy:

    • Levetiracetam: 500-1000 mg IV (effective for post-anoxic myoclonus) 1, 2
    • Sodium valproate: 20-40 mg/kg IV loading dose (avoid in women of childbearing age) 2
  3. For refractory cases:

    • Propofol: Consider for severe, persistent myoclonus requiring immediate suppression 1, 2
    • General anesthesia with neuromuscular blockade may be necessary in extreme cases 3, 4

Diagnostic Evaluation

  • EEG monitoring: Consider intermittent or continuous EEG to determine if myoclonus has epileptiform correlates 1, 2

  • Laboratory tests: Check electrolytes, glucose, calcium, and magnesium levels to rule out metabolic causes 3, 4

  • Neuroimaging: Consider brain and spinal MRI if myoclonus persists beyond 24 hours to rule out structural lesions 2

Special Considerations

  • Medication-induced myoclonus: Intrathecal bupivacaine has been reported as a potential cause of spinal myoclonus 3, 4

  • Opioid-induced myoclonus: If intrathecal opioids were used, they may contribute to myoclonus development 5, 6

    • Consider opioid rotation or dose reduction if this is suspected
  • Duration of treatment: Myoclonus following subarachnoid block may resolve spontaneously within 24-48 hours, but some cases may require prolonged treatment 3, 4

Monitoring and Follow-up

  • Continuous monitoring: For the first 24 hours, especially if status myoclonus is present 1

  • Prolonged observation: Necessary after treatment of seizures, especially in patients with status myoclonicus 2

  • Reassessment: Evaluate response to therapy every 2-4 hours and adjust treatment accordingly

Cautions and Pitfalls

  • Avoid phenytoin and carbamazepine: These can paradoxically worsen cortical myoclonus 2

  • Respiratory depression: Monitor closely when using multiple sedative medications

  • Distinguish from seizures: Myoclonus may be mistaken for seizure activity; EEG can help differentiate 1, 2

  • Rule out Lance-Adams syndrome: If myoclonus persists after recovery from anesthesia, consider this diagnosis, which requires long-term management 2

Myoclonus after subarachnoid block is rare but can be distressing for both patient and provider. Prompt recognition and appropriate treatment are essential to prevent complications and ensure patient comfort.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lance-Adams Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Spinal Myoclonus: Is It An Anesthetic Mystery?

Revista espanola de anestesiologia y reanimacion, 2020

Research

Spinal myoclonus after subarachnoid anesthesia with bupivacaine.

Revista brasileira de anestesiologia, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.